Name: Latest research reports of Laurus Labs Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Laurus Labs Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

862.5500 31.60 (3.80%)

NSE Aug 13, 2025 15:09 PM

106.50% Gain from 52W Low

Volume: 2.6M

Laurus Labs Ltd.

29 Jan 2021

862.55

3.80%

Laurus Labs (BUY): Solid margins despite higher API mix TP raised to Rs 480

Buy: Laurus Labs Ltd.

Target

BOB Capital Markets Ltd.

Laurus Labs reported another solid beat in Q3FY21 fuelled by strong growth in the API and synthesis segments.

Laurus Labs Ltd. has gained 45.35% in the last 3 Months